Browse Studies — Arctuva

Caregiving Networks Across Disease Context and the Life Course: A Comparative Longitudinal Study

Background: In the U.S., about 53 million informal, unpaid caregivers provide care to a person who is ill, is disabled, or has age-related loss of function. T…

Inherited Metabolic DisordersUndiagnosed DiseasesBatten's Disease+2 more

Estimated

~$10 – $675

National Human Genome Research Institute (NHGRI)NCT05007990

Phase 2

Cord Blood Transplantation in Children and Young Adults With Hematologic Malignancies and Non-malignant Disorders

This is a single-arm study to investigate 1-year treatment related mortality (TRM) in patients with life threatening non-malignant and malignant hematologic di…

AMLALLMDS+6 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT04644016

A Prospective Outcomes Study of Pediatric and Adult Patients With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation With a Reduced-Intensity Conditioning Regimen (PRO-RIC)

This is a data collection study that will examine the general diagnostic and treatment data associated with the reduced-intensity chemotherapy-based regimen pa…

Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more

Estimated

~$10 – $1,125

Paul SzabolcsNCT04528355

Phase 2

A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation

The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), doubl…

Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more

Estimated

~$10 – $7,500

Paul SzabolcsNCT01962415